Jed brings business development and investment experience to Tundra, which he joined after leading a corporate venture capital firm. Previously he helped commercialize DSM Biomedical's first cell therapy products and launched US and global distribution through partners like J&J. He also led a startup company, Nerites, through a series of life sciences transactions culminating in acquisition by Kensey Nash.